2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Heidenreich, Paul A; Bozkurt, Biykem; Aguilar, David; Allen, Larry A; Byun, Joni J; Colvin, Monica M; Deswal, Anita; Drazner, Mark H; Dunlay, Shannon M; Evers, Linda R; Fang, James C; Fedson, Savitri E; Fonarow, Gregg C; Hayek, Salim S; Hernandez, Adrian F; Khazanie, Prateeti; Kittleson, Michelle M; Lee, Christopher S; Link, Mark S; Milano, Carmelo A; Nnacheta, Lorraine C; Sandhu, Alexander T; Stevenson, Lynne Warner; Vardeny, Orly; Vest, Amanda R; Yancy, Clyde W

Heidenreich, Paul A; Bozkurt, Biykem; Aguilar, David; Allen, Larry A; Byun, Joni J; Colvin, Monica M; Deswal, Anita; Drazner, Mark H; Dunlay, Shannon M; Evers, Linda R; Fang, James C; Fedson, Savitri E; Fonarow, Gregg C; Hayek, Salim S; Hernandez, Adrian F; Khazanie, Prateeti; Kittleson, Michelle M; Lee, Christopher S; Link, Mark S; Milano, Carmelo A; Nnacheta, Lorraine C; Sandhu, Alexander T; Stevenson, Lynne Warner; Vardeny, Orly; Vest, Amanda R; Yancy, Clyde W.

Afiliação

Heidenreich PA; ACC/AHA Representative.
Bozkurt B; ACC/AHA Representative.
Aguilar D; ACC/AHA Representative.
Allen LA; ACC/AHA Representative.
Byun JJ; ACC/AHA Representative.
Colvin MM; ACC/AHA Representative.
Deswal A; ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison.
Drazner MH; ACC/AHA Representative.
Dunlay SM; ACC/AHA Representative.
Evers LR; ACC/AHA Representative.
Fang JC; ACC/AHA Representative.
Fedson SE; ACC/AHA Representative.
Fonarow GC; ACC/AHA Task Force on Performance Measures Representative.
Hayek SS; ACC/AHA Representative.
Hernandez AF; ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison.
Khazanie P; ACC/AHA Representative.
Kittleson MM; ACC/AHA Representative.
Lee CS; ACC/AHA Representative.
Link MS; ACC/AHA Representative.
Milano CA; ACC/AHA Representative.
Nnacheta LC; ACC/AHA Representative.
Sandhu AT; ACC/AHA Representative.
Stevenson LW; ACC/AHA Representative.
Vardeny O; HFSA Representative.
Vest AR; HFSA Representative.
Yancy CW; ACC/AHA Representative.

Circulation ; 145(18): e876-e894, 2022 05 03.

Article em En | MEDLINE | ID: mdl-35363500

Assuntos

Cardiologia; Sistema Cardiovascular; Insuficiência Cardíaca; American Heart Association; Insuficiência Cardíaca/tratamento farmacológico; Insuficiência Cardíaca/terapia; Humanos; Relatório de Pesquisa; Estados Unidos

Palavras-chave

ACE inhibitors; AHA Scientific Statements; SGLT2 inhibitors; acute decompensated heart failure; angiotensin and neprilysin receptor antagonist; angiotensin receptor antagonist; atrial fibrillation; beta blockers; cardiac amyloidosis; cardiac failure; cardio-oncology; cardiogenic shock; cardiomyopathy; cardiomyopathy in pregnancy; chronic heart failure; congestive heart failure; diabetes; guideline-directed medical therapy; heart failure; heart failure rehabilitation; heart failure with mildly reduced ejection fraction; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; mineralocorticoid receptor antagonists; mitral regurgitation; palliative care; reduced ejection fraction; right heart pressure; sacubitril valsartan; social determinants of health; sodium glucose co-transporter 2; systolic heart failure; valvular heart disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cardiologia / Sistema Cardiovascular / Insuficiência Cardíaca Tipo de estudo: Guideline / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Circulation Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google